tiprankstipranks
Inspire Veterinary Partners, Inc. Class A (IVP)
NASDAQ:IVP
US Market

Inspire Veterinary Partners, Inc. Class A (IVP) AI Stock Analysis

Compare
409 Followers

Top Page

IV

Inspire Veterinary Partners, Inc. Class A

(NASDAQ:IVP)

38Underperform
Inspire Veterinary Partners, Inc. Class A faces significant financial challenges, including consistent losses and high leverage, which weigh heavily on the overall stock score. Technical indicators suggest a bearish trend, and the valuation metrics are unfavorable due to negative earnings. While the recent stock offering provides a potential positive outlook for future growth, the overall financial health and market conditions remain primary concerns.

Inspire Veterinary Partners, Inc. Class A (IVP) vs. S&P 500 (SPY)

Inspire Veterinary Partners, Inc. Class A Business Overview & Revenue Model

Company DescriptionInspire Veterinary Partners, Inc. Class A (IVP) is a company operating in the veterinary services sector, focusing on providing comprehensive care and management solutions for veterinary practices. The company is dedicated to enhancing the quality of animal healthcare through innovative strategies and partnerships, promoting the growth and efficiency of veterinary clinics.
How the Company Makes MoneyInspire Veterinary Partners, Inc. makes money primarily through its ownership and management of veterinary practices. The company generates revenue by offering a range of services including practice management, operational support, and consulting to enhance the efficiency and profitability of these clinics. Revenue streams include service fees, consulting charges, and a share of the profits from the veterinary clinics they manage or own. Key revenue drivers also include strategic partnerships with suppliers and service providers that help optimize the practices under their management.

Inspire Veterinary Partners, Inc. Class A Financial Statement Overview

Summary
Inspire Veterinary Partners, Inc. Class A is navigating a difficult financial landscape characterized by revenue growth but persistent profitability challenges and high leverage. The income statement indicates consistent losses, while the balance sheet reflects a heavy reliance on debt with limited equity, posing risks to financial stability. Cash flow constraints further exacerbate the situation, highlighting a need for improved cash management and operational efficiency to sustain future growth and stability.
Income Statement
35
Negative
The income statement reveals a challenging financial position for Inspire Veterinary Partners, Inc. Class A. The company has experienced revenue growth over the years, with the most recent TTM (Trailing-Twelve-Months) revenue at $17.05 million, up from $16.68 million the previous year. However, the firm is struggling with negative profitability, as evidenced by a negative net profit margin and EBIT margin. The company has consistently reported net losses, with the latest net income at -$14.44 million, indicating significant profitability challenges.
Balance Sheet
40
Negative
The balance sheet shows a highly leveraged position, with a debt-to-equity ratio that indicates significant reliance on debt financing. As of the latest period, total debt stands at $16.99 million against stockholders' equity of $3.03 million. Although stockholders' equity has improved from a negative position in previous years, the company's equity ratio remains low, reflecting potential financial vulnerability. The increase in stockholders' equity is a positive sign, but the high debt levels pose ongoing risks.
Cash Flow
30
Negative
Cash flow analysis shows that Inspire Veterinary Partners, Inc. Class A is facing considerable cash flow challenges. The company reported negative operating cash flow of -$10.08 million and free cash flow of -$10.30 million in the latest TTM period. Although there is some capital raised through financing activities, it has not been sufficient to cover operational needs, resulting in negative cash flow to net income ratios. These figures suggest ongoing liquidity issues that may impact future operations.
Breakdown
TTMDec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
17.05M16.68M9.83M2.55M0.00
Gross Profit
2.20M3.55M2.55M829.29K0.00
EBIT
-9.18M-7.19M-3.52M-1.05M-5.52K
EBITDA
-9.17M-10.84M-2.91M-977.46K0.00
Net Income Common Stockholders
-14.44M-14.79M-4.91M-1.33M-5.52K
Balance SheetCash, Cash Equivalents and Short-Term Investments
21.97K178.96K444.25K2.06M21.97K
Total Assets
0.0021.79M20.19M6.33M21.97K
Total Debt
0.0018.42M23.61M6.69M0.00
Net Debt
21.97K18.24M23.17M4.64M-21.97K
Total Liabilities
0.0022.58M25.32M7.20M0.00
Stockholders Equity
21.97K-788.26K-5.14M-869.09K21.97K
Cash FlowFree Cash Flow
-10.31M-4.20M-2.84M-2.32M-5.52K
Operating Cash Flow
-10.08M-3.82M-2.66M-1.01M-5.52K
Investing Cash Flow
-1.71M-1.87M-14.67M-4.02M0.00
Financing Cash Flow
10.72M5.63M15.71M7.07M269.16K

Inspire Veterinary Partners, Inc. Class A Technical Analysis

Technical Analysis Sentiment
Negative
Last Price1.72
Price Trends
50DMA
2.29
Negative
100DMA
3.76
Negative
200DMA
37.55
Negative
Market Momentum
MACD
-0.17
Negative
RSI
34.18
Neutral
STOCH
10.67
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IVP, the sentiment is Negative. The current price of 1.72 is below the 20-day moving average (MA) of 1.88, below the 50-day MA of 2.29, and below the 200-day MA of 37.55, indicating a bearish trend. The MACD of -0.17 indicates Negative momentum. The RSI at 34.18 is Neutral, neither overbought nor oversold. The STOCH value of 10.67 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IVP.

Inspire Veterinary Partners, Inc. Class A Risk Analysis

Inspire Veterinary Partners, Inc. Class A disclosed 48 risk factors in its most recent earnings report. Inspire Veterinary Partners, Inc. Class A reported the most risks in the “Finance & Corporate” category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Inspire Veterinary Partners, Inc. Class A Peers Comparison

Overall Rating
UnderperformOutperform
Sector (59)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
ZTZTS
79
Outperform
$73.04B29.8450.91%1.10%8.33%7.70%
73
Outperform
$33.70B38.9957.66%6.46%5.82%
65
Neutral
$5.15B15.345.49%0.50%
59
Neutral
$12.26B11.12-0.55%3.78%1.42%-20.63%
IVIVP
38
Underperform
$3.91M-502.92%6.12%70.51%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IVP
Inspire Veterinary Partners, Inc. Class A
1.71
-112.04
-98.50%
IDXX
Idexx Laboratories
419.95
-112.46
-21.12%
ZTS
Zoetis
164.65
-0.61
-0.37%
ELAN
Elanco Animal Health
10.50
-5.47
-34.25%

Inspire Veterinary Partners, Inc. Class A Corporate Events

Delistings and Listing ChangesStock Split
Inspire Veterinary Partners Announces Reverse Stock Split
Neutral
Jan 23, 2025

On January 22, 2025, Inspire Veterinary Partners, Inc. announced a 1-for-25 reverse stock split of its Class A common stock, effective January 27, 2025. This move is intended to help the company comply with Nasdaq’s $1.00 minimum bid price requirement to maintain its listing. The reverse stock split will not affect any stockholder’s percentage interest in the company’s equity, and all changes will be uniformly applied.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.